Article: Teva Receives Final Approval for Generic Prevacid[R] Delayed-Release Capsules.

Article: IMPAX and Teva Launch Omeprazole Delayed Release ...
Business Wire;  September 8, 2004 ;     700+ words ... ... Omeprazole Delayed Release Capsules 20mg have been ... launched by Teva Pharmaceutical Industries Ltd. (Nasdaq ... Omeprazole Delayed Release Capsules are a generic ... Omeprazole Delayed Release Capsules, 10mg, and 20mg ...

Article: Pharmaceutical company launches Omeprazole Delayed Release ...
Drug Week;  October 1, 2004 ;     616 words ... ... Omeprazole Delayed Release Capsules 20 mg have been ... launched by Teva Pharmaceutical Industries Ltd. (TEVA). Omeprazole Delayed Release Capsules are a generic version ... Omeprazole Delayed Release Capsules, 10mg, and 20mg ...

Article: Teva Gets Final OK for Generic Prevacid Delayed-Release ...
Health & Beauty Close-Up;  November 13, 2009 ;     523 words ...Teva Pharmaceutical Industries has announced that the U.S ... Prevacid (lansoprazole) Delayed-Release Capsules, 15 mg and 30 mg. Customers ... based on IMS sales data. Teva Pharmaceutical Industries, headquartered in Israel, is ...

Article: Barr Confirms Patent Challenge of Amrix(R) ...
PR Newswire;  November 26, 2008 ;     700+ words ... ... hydrochloride) extended-release capsules, 15mg and 30mg. Barr filed ... hydrochloride) extended-release capsules, 15mg and 30mg had annual ... owned subsidiary of Teva Pharmaceutical Industries Ltd. (the "Teva") and ...

Article: Teva Announces Tentative Approval of Generic Prevacid(R) ...
Business Wire;  January 23, 2008 ;     700+ words ...JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ... Lansoprazole) Delayed-release Capsules, 15 mg and 30 mg. The ... litigation. About Teva Teva Pharmaceutical Industries Ltd., headquartered in ...

Article: Cephalon and Eurand Announce Notification of Generic Filing for ...
PR Newswire;  October 21, 2008 ;     700+ words ... ... AMRIX(R) (Cyclobenzaprine Hydrochloride Extended-Release Capsules). In the Notice Letter, Mylan alleges that the U ... political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing ...

Article: Use of Monensin Controlled-Release Capsules to ...
Journal of Dairy Science;  March 1, 2008 ;     700+ words ... ... monensin, provided by controlled-release capsules, on the enteric methane emissions ... monensin group received 2 controlled-release capsules, with the second capsule administered ... the effects of monensin controlled-release capsules on methane emissions and dry matter ...